Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

PHASE2RecruitingINTERVENTIONAL

Enrollment

860

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions

Proliferative VitreoretinopathyRhegmatogenous Retinal Detachment

Interventions

DRUG

Methotrexate Injection

Methotrexate injection

DRUG

Methotrexate Infusion

DRUG

Sham Injection

Trial Locations (1)

RECRUITING

Cincinnati Eye Institute, Cincinnati

All Listed Sponsors

lead

Cincinnati Eye Institute, Southwest Ohio

OTHER